Meta-analysis identifies seven susceptibility loci involved in the atopic March

Nature Communications

Volumn 6, Issue , 2015, Pages

  Marenholz, Ingo ^a,b   Esparza Gordillo, Jorge ^a,b   Rüschendorf, Franz ^a   Bauerfeind, Anja ^a   Strachan, David P ^c   Spycher, Ben D ^d   Baurecht, Hansjörg ^e   Margaritte Jeannin, Patricia ^f,g   Sääf, Annika ^h   Kerkhof, Marjan ⁱ   Ege, Markus ^j   Baltic, Svetlana ^k   Matheson, Melanie C ^l   Li, Jin ^m   Michel, Sven ⁿ   Ang, Wei Q ^o   McArdle, Wendy ^p   Arnold, Andreas ^q   Homuth, Georg ^q   Demenais, Florence ^f,g   Bouzigon, Emmanuelle ^f,g   Söderhäll, Cilla ^h   Pershagen, Göran ^h   De Jongste, Johan C ^r   Postma, Dirkje S ⁱ   Braun Fahrländer, Charlotte ^s   Horak, Elisabeth ^t   Ogorodova, Ludmila M ^u   Puzyrev, Valery P ^u,v   Bragina, Elena Yu ^v   Hudson, Thomas J ^w   Morin, Charles ^x   Duffy, David L ^y   Marks, Guy B ^z   Robertson, Colin F ^aa   Montgomery, Grant W ^y   Musk, Bill ^ab   Thompson, Philip J ^k   Martin, Nicholas G ^y   James, Alan ^ab   Sleiman, Patrick ^m,ac   Toskala, Elina ^ad   Rodriguez, Elke ^e   Fölster Holst, Regina ^e   Franke, Andre ^ae   Lieb, Wolfgang ^ae   Gieger, Christian ^af   Heinzmann, Andrea ^ag   Rietschel, Ernst ^ah   Keil, Thomas ^b,ai   Cichon, Sven ^aj,ak,al   Nöthen, Markus M ^aj   Pennell, Craig E ^o   Sly, Peter D ^am   Schmidt, Carsten O ^q   Matanovic, Anja ^a,b   Schneider, Valentin ^a   Heinig, Matthias ^a,an   Hübner, Norbert ^a   Holt, Patrick G ^am,ao   Lau, Susanne ^b   Kabesch, Michael ⁿ   Weidinger, Stefan ^e   Hakonarson, Hakon ^m,ac   Ferreira, Manuel A R ^y   Laprise, Catherine ^ap   Freidin, Maxim B ^v   Genuneit, Jon ^aq   Koppelman, Gerard H ^ar   Melén, Erik ^h,as   Dizier, Marie Hélène ^f,g   Henderson, A John ^p   Lee, Young Ae ^a,b   more..

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c ST GEORGE S HOSPITAL   (United Kingdom)

^d UNIVERSITY OF BERN   (Switzerland)

^e UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^f Centre D'Etude du Polymorphisme Humain   (France)

^g UNIVERSITÉ PARIS DIDEROT   (France)

^h KAROLINSKA INSTITUTE   (Sweden)

ⁱ UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^j LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^k UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^l UNIVERSITY OF MELBOURNE   (Australia)

^m CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

ⁿ UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^o UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^p UNIVERSITY OF BRISTOL   (United Kingdom)

^q UNIVERSITY MEDICINE GREIFSWALD   (Germany)

^r ERASMUS MEDICAL CENTER   (Netherlands)

^s UNIVERSITY OF BASEL   (Switzerland)

^t INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^u SIBERIAN STATE MEDICAL UNIVERSITY   (Russian Federation)

^v RESEARCH INSTITUTE OF MEDICAL GENETICS   (Russian Federation)

^w ONTARIO INSTITUTE FOR CANCER RESEARCH   (Canada)

^x Gouvernement du Quebec   (Canada)

^y QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^z UNIVERSITY OF SYDNEY   (Australia)

^aa MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^ab SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^ac UNIVERSITY OF PENNSYLVANIA   (United States)

^ad TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^ae UNIVERSITY OF KIEL   (Germany)

^af INSTITUTE OF EPIDEMIOLOGY   (Germany)

^ag UNIVERSITY OF FREIBURG   (Germany)

^ah UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^ai UNIVERSITY OF WÜRZBURG   (Germany)

^aj UNIVERSITY OF BONN   (Germany)

^ak UNIVERSITY HOSPITAL BASEL   (Switzerland)

^al FORSCHUNGSZENTRUM JÜLICH   (Germany)

^am UNIVERSITY OF QUEENSLAND   (Australia)

^an MAX PLANCK INSTITUTE FOR MOLECULAR GENETICS   (Germany)

^ao UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^ap UNIVERSITÉ DU QUÉBEC À CHICOUTIMI   (Canada)

^aq UNIVERSITY OF ULM   (Germany)

^ar UNIVERSITY OF GRONINGEN   (Netherlands)

^as SACHS CHILDREN S HOSPITAL   (Sweden)

more..

Author keywords

[No Author keywords available]

Indexed keywords

META-ANALYSIS;

ADOLESCENT; ARTICLE; ASTHMA; ATOPIC DERMATITIS; CHROMOSOME 12Q; CHROMOSOME 6P; CONTROLLED STUDY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS (TOPIC); PHENOTYPE; SINGLE NUCLEOTIDE POLYMORPHISM; ADULT; CHILD; DISEASE COURSE; FEMALE; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; MALE; META ANALYSIS; MIDDLE AGED; PRESCHOOL CHILD; STATISTICAL MODEL; YOUNG ADULT;

AMINO ACID TRANSPORTER; AP5B1 PROTEIN, HUMAN; C11ORF30 PROTEIN, HUMAN; CALCIUM BINDING PROTEIN; CARRIER PROTEIN; DNA BINDING PROTEIN; EFHC1 PROTEIN, HUMAN; FGFR1 PROTEIN, HUMAN; FIBROBLAST GROWTH FACTOR RECEPTOR 1; IKAROS TRANSCRIPTION FACTOR; IKZF3 PROTEIN, HUMAN; IL4 PROTEIN, HUMAN; INTERLEUKIN 4; KIF3A PROTEIN, HUMAN; KINESIN; LRRC32 PROTEIN, HUMAN; MEMBRANE PROTEIN; NERVE PROTEIN; NUCLEAR PROTEIN; OVOL1 PROTEIN, HUMAN; REPRESSOR PROTEIN; SLC6A15 PROTEIN, HUMAN; TMTC2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TUMOR PROTEIN; VESICULAR TRANSPORT ADAPTOR PROTEIN;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; ADOLESCENT; ADULT; AMINO ACID TRANSPORT SYSTEMS, NEUTRAL; ASTHMA; CALCIUM-BINDING PROTEINS; CARRIER PROTEINS; CHILD; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; DISEASE PROGRESSION; DNA-BINDING PROTEINS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; IKAROS TRANSCRIPTION FACTOR; INTERLEUKIN-4; KINESIN; LOGISTIC MODELS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NEOPLASM PROTEINS; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; REPRESSOR PROTEINS; TRANSCRIPTION FACTORS; YOUNG ADULT;

EID: 84946594844     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms9804     Document Type: Article

References (70)

1. Dharmage, S. C. et al. Atopic dermatitis and the atopic march revisited. Allergy 69, 17-27 (2014).
2. Spergel, J. M. From atopic dermatitis to asthma: the atopic march. Ann. Allergy Asthma Immunol. 105, 99-106 (2010).
3. Almqvist, C. et al. Early predictors for developing allergic disease and asthma: examining separate steps in the 'allergic march'. Clin. Exp. Allergy 37, 1296-1302 (2007).
4. Ricci, G. et al. Long-term follow-up of atopic dermatitis: retrospective analysis of related risk factors and association with concomitant allergic diseases. J. Am. Acad. Dermatol. 55, 765-771 (2006).
5. Leung, D. Y. & Guttman-Yassky, E. Deciphering the complexities of atopic dermatitis: shifting paradigms in treatment approaches. J. Allergy Clin. Immunol. 134, 769-779 (2014).
6. Li, M. Current evidence of epidermal barrier dysfunction and thymic stromal lymphopoietin in the atopic march. Eur. Respir. Rev. 23, 292-298 (2014).
7. Kemeny, L. & Szabo, K. Toll-like receptors link atopic march to the hygiene hypothesis. J. Invest. Dermatol. 133, 874-878 (2013).
8. Palmer, C. N. et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat. Genet. 38, 441-446 (2006).
9. Marenholz, I. et al. Filaggrin loss-of-function mutations predispose to phenotypes involved in the atopic march. J. Allergy Clin. Immunol. 118, 866-871 (2006).
10. Punekar, Y. S. & Sheikh, A. Establishing the sequential progression of multiple allergic diagnoses in a UK birth cohort using the General Practice Research Database. Clin. Exp. Allergy 39, 1889-1895 (2009).
11. Freedman, M. L. et al. Assessing the impact of population stratification on genetic association studies. Nat. Genet. 36, 388-393 (2004).
12. Paternoster, L. et al. Meta-analysis of genome-wide association studies identifies three new risk loci for atopic dermatitis. Nat. Genet. 44, 187-192 (2012).
13. Marenholz, I. et al. The eczema risk variant on chromosome 11q13 (rs7927894) in the population-based ALSPAC cohort: a novel susceptibility factor for asthma and hay fever. Hum. Mol. Genet. 20, 2443-2449 (2011).
14. Esparza-Gordillo, J. et al. A common variant on chromosome 11q13 is associated with atopic dermatitis. Nat. Genet. 41, 596-601 (2009).
15. Moffatt, M. F. et al. Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma. Nature 448, 470-473 (2007).
16. Bisgaard, H. et al. Chromosome 17q21 gene variants are associated with asthma and exacerbations but not atopy in early childhood. Am. J. Respir. Crit. Care Med. 179, 179-185 (2009).
17. Halapi, E. et al. A sequence variant on 17q21 is associated with age at onset and severity of asthma. Eur. J. Hum. Genet. 18, 902-908 (2010).
18. Hinds, D. A. et al. A genome-wide association meta-analysis of self-reported allergy identifies shared and allergy-specific susceptibility loci. Nat. Genet. 45, 907-911 (2013).
19. Ferreira, M. A. et al. Genome-wide association analysis identifies 11 risk variants associated with the asthma with hay fever phenotype. J. Allergy Clin. Immunol. 133, 1564-1571 (2014).
20. Lappalainen, T. et al. Transcriptome and genome sequencing uncovers functional variation in humans. Nature 501, 506-511 (2013).
21. ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57-74 (2012).
22. Kundaje, A. et al. Integrative analysis of 111 reference human epigenomes. Nature 518, 317-330 (2015).
23. Eppig, J. T., Blake, J. A., Bult, C. J., Kadin, J. A. & Richardson, J. E. The Mouse Genome Database (MGD): facilitating mouse as a model for human biology and disease. Nucleic Acids Res. 43, D726-D736 (2015).
24. Forrest, A. R. et al. A promoter-level mammalian expression atlas. Nature 507, 462-470 (2014).
25. Johnson, A. D. et al. SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap. Bioinformatics 24, 2938-2939 (2008).
26. Sunryd, J. C. et al. TMTC1 and TMTC2 are novel endoplasmic reticulum tetratricopeptide repeat-containing adapter proteins involved in calcium homeostasis. J. Biol. Chem. 289, 16085-16099 (2014).
27. Welter, D. et al. The NHGRI GWAS Catalog, a curated resource of SNP-trait associations. Nucleic Acids Res. 42, D1001-D1006 (2014).
28. Medina, M. T. et al. Novel mutations in Myoclonin1/EFHC1 in sporadic and familial juvenile myoclonic epilepsy. Neurology 70, 2137-2144 (2008).
29. Annesi, F. et al. Mutational analysis of EFHC1 gene in Italian families with juvenile myoclonic epilepsy. Epilepsia 48, 1686-1690 (2007).
30. Ma, S. et al. Mutations in the GABRA1 and EFHC1 genes are rare in familial juvenile myoclonic epilepsy. Epilepsy Res. 71, 129-134 (2006).
31. Stogmann, E. et al. Idiopathic generalized epilepsy phenotypes associated with different EFHC1 mutations. Neurology 67, 2029-2031 (2006).
32. Suzuki, T. et al. Mutations in EFHC1 cause juvenile myoclonic epilepsy. Nat. Genet. 36, 842-849 (2004).
33. Suzuki, T. et al. Efhc1 deficiency causes spontaneous myoclonus and increased seizure susceptibility. Hum. Mol. Genet. 18, 1099-1109 (2009).
34. Ikeda, T. et al. The mouse ortholog of EFHC1 implicated in juvenile myoclonic epilepsy is an axonemal protein widely conserved among organisms with motile cilia and flagella. FEBS Lett. 579, 819-822 (2005).
35. Thomas, B. et al. Ciliary dysfunction and ultrastructural abnormalities are features of severe asthma. J. Allergy Clin. Immunol. 126, 722-729 (2010).
36. Silverberg, J. I., Joks, R. & Durkin, H. G. Allergic disease is associated with epilepsy in childhood: a US population-based study. Allergy 69, 95-103 (2014).
37. Drgonova, J. et al. Involvement of the neutral amino acid transporter SLC6A15 and leucine in obesity-related phenotypes. PLoS ONE 8, e68245 (2013).
38. Schuhmacher, A. et al. A variant of the neuronal amino acid transporter SLC6A15 is associated with ACTH and cortisol responses and cognitive performance in unipolar depression. Int. J. Neuropsychopharmacol. 16, 83-90 (2013).
39. Kohli, M. A. et al. The neuronal transporter gene SLC6A15 confers risk to major depression. Neuron 70, 252-265 (2011).
40. Cuboni, S. et al. Loratadine and analogues: discovery and preliminary structureactivity relationship of inhibitors of the amino acid transporter B(0)AT2. J. Med. Chem. 57, 9473-9479 (2014).
41. Pasparakis, M., Haase, I. & Nestle, F. O. Mechanisms regulating skin immunity and inflammation. Nat. Rev. Immunol. 14, 289-301 (2014).
42. Kawasaki, H. et al. Altered stratum corneum barrier and enhanced percutaneous immune responses in filaggrin-null mice. J. Allergy Clin. Immunol. 129, 1538-1546 (2012).
43. Spergel, J. M. et al. Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice. J. Clin. Invest. 101, 1614-1622 (1998).
44. Horimukai, K. et al. Application of moisturizer to neonates prevents development of atopic dermatitis. J. Allergy Clin. Immunol. 134, 824-830 (2014).
45. Simpson, E. L. et al. Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention. J. Allergy Clin. Immunol. 134, 818-823 (2014).
46. Ballardini, N. et al. Infantile eczema: prognosis and risk of asthma and rhinitis in preadolescence. J. Allergy Clin. Immunol. 133, 594-596 (2014).
47. Saunes, M. et al. Early eczema and the risk of childhood asthma: a prospective, population-based study. BMC Pediatr. 12, 168 (2012).
48. von Kobyletzki, L. B. et al. Eczema in early childhood is strongly associated with the development of asthma and rhinitis in a prospective cohort. BMC Dermatol. 12, 11 (2012).
49. Martin, P. E. et al. Childhood eczema and rhinitis predict atopic but not nonatopic adult asthma: a prospective cohort study over 4 decades. J. Allergy Clin. Immunol. 127, 1473-1479 (2011).
50. Belgrave, D. C. et al. Developmental profiles of eczema, wheeze, and rhinitis: two population-based birth cohort studies. PLoS Med. 11, e1001748 (2014).
51. Noti, M. et al. Exposure to food allergens through inflamed skin promotes intestinal food allergy through the thymic stromal lymphopoietin-basophil axis. J. Allergy Clin. Immunol. 133, 1390-1399 (2014).
52. Bihouee, T. et al. Food allergy enhances allergic asthma in mice. Respir. Res. 15, 142 (2014).
53. Longo, G., Berti, I., Burks, A. W., Krauss, B. & Barbi, E. IgE-mediated food allergy in children. Lancet 382, 1656-1664 (2013).
54. Chafen, J. J. et al. Diagnosing and managing common food allergies: a systematic review. JAMA 303, 1848-1856 (2010).
55. Keil, T. et al. The multinational birth cohort of EuroPrevall: background, aims and methods. Allergy 65, 482-490 (2010).
56. Rona, R. J. et al. The prevalence of food allergy: a meta-analysis. J. Allergy Clin. Immunol. 120, 638-646 (2007).
57. Ramasamy, A. et al. A genome-wide meta-analysis of genetic variants associated with allergic rhinitis and grass sensitization and their interaction with birth order. J. Allergy Clin. Immunol. 128, 996-1005 (2011).
58. Spergel, J. M. Epidemiology of atopic dermatitis and atopic march in children. Immunol. Allergy Clin. North Am. 30, 269-280 (2010).
59. Kapoor, R. et al. The prevalence of atopic triad in children with physicianconfirmed atopic dermatitis. J. Am. Acad. Dermatol. 58, 68-73 (2008).
60. van der Hulst, A. E., Klip, H. & Brand, P. L. Risk of developing asthma in young children with atopic eczema: a systematic review. J. Allergy Clin. Immunol. 120, 565-569 (2007).
61. Moffatt, M. F. et al. A large-scale, consortium-based genomewide association study of asthma. N. Engl. J. Med. 363, 1211-1221 (2010).
62. Patterson, N., Price, A. L. & Reich, D. Population structure and eigenanalysis. PLoS Genet. 2, e190 (2006).
63. Li, Y., Willer, C. J., Ding, J., Scheet, P. & Abecasis, G. R. MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes. Genet. Epidemiol. 34, 816-834 (2010).
64. Howie, B. N., Donnelly, P. & Marchini, J. A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet. 5, e1000529 (2009).
65. Williams, R. L. A note on robust variance estimation for cluster-correlated data. Biometrics 56, 645-646 (2000).
66. Willer, C. J., Li, Y. & Abecasis, G. R. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics 26, 2190-2191 (2010).
67. Henderson, J. et al. The burden of disease associated with filaggrin mutations: a population-based, longitudinal birth cohort study. J. Allergy Clin. Immunol. 121, 872-877 (2008).
68. Ballardini, N. et al. Eczema severity in preadolescent children and its relation to sex, filaggrin mutations, asthma, rhinitis, aggravating factors and topical treatment: a report from the BAMSE birth cohort. Br. J. Dermatol. 168, 588-594 (2013).
69. Schuttelaar, M. L. et al. Filaggrin mutations in the onset of eczema, sensitization, asthma, hay fever and the interaction with cat exposure. Allergy 64, 1758-1765 (2009).
70. Sandilands, A. et al. Comprehensive analysis of the gene encoding filaggrin uncovers prevalent and rare mutations in ichthyosis vulgaris and atopic eczema. Nat. Genet. 39, 650-654 (2007).